Xue Pan

Liquid chromatography-mass spectrometry based tissue metabolic profiling reveals major metabolic pathway alterations and potential biomarkers of lung cancer.

Guowang Xu, Zaifang Li, S. Shao, 2020, Journal of proteome research.

Lipid alterations and subtyping maker discovery of lung cancer based on nontargeted tissue lipidomics using liquid chromatography-mass spectrometry.

Guowang Xu, Xinyu Liu, Xiangnan Li, 2020, Journal of pharmaceutical and biomedical analysis.

The circRNA circ_0000291 acts as a sponge of microRNA 326 to regulate E26 transformation‐specific sequence‐1 expression and promote breast cancer progression

J. Min, G. Lv, Xue Pan, 2020, Pathology international.

VPS53 Suppresses Malignant Properties in Colorectal Cancer by Inducing the Autophagy Signaling Pathway

Hong Wu, Jie Zheng, L. Gong, 2020, OncoTargets and therapy.

Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers

Haojie Huang, Xiaocui Zhang, Xinru Liu, 2019, Therapeutic advances in gastroenterology.

Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms

Q. Su, Tao Liu, Hong-Qi Peng, 2021, Bioengineered.